New study finds that Black children and those identifying with more than one race have higher disease activity and are less likely to achieve low lupus disease activity state compared to White ...

A support group is a gathering of people facing common issues to share what’s troubling them. Through the sharing of experiences, they can offer support, encouragement, and comfort to the other group ...

In a new study, researchers looked to identify unique biomarkers and shared microbial mechanisms among different autoimmune ...

Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN).

In a new study, researchers investigated the prevalence of cardiovascular disease events (CVE) in people with systemic lupus ...

Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE).

UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...

Systemic lupus erythematosus (SLE) predisposes individuals to early cardiovascular (CV) events, such as myocardial infarction (heart attack), stroke, and other thromboembolic events.